Top Markets
#1 CoW Protocol CoW Protocol +60.76%
#2 EXOD EXOD +56.80%
#3 Glidr Glidr +38.71%
#4 Walrus Walrus +26.07%
#5 Tutorial Tutorial +18.44%
#6 Cysic Cysic +17.50%
#7 Velvet Velvet +17.00%
#8 The Black Bull The Black Bull +15.70%
#9 Arowana Arowana +15.67%
#10 Nockchain Nockchain +14.18%
Coin of the day
CoW Protocol CoW Protocol
Settings
Language
ENGLISH
Currency
USD
Theme
Decoy Therapeutics Inc. Decoy Therapeutics Inc.

Decoy Therapeutics Inc.

DCOY
Rank in Stocks #37225
Based in Cambridge, Massachusetts, Decoy Therapeutics Inc. is an early-stage... Based in Cambridge, Massachusetts, Decoy Therapeutics Inc. is an early-stage biotechnology firm dedicated to tackling critical unmet medical needs. The company employs cutting-edge machine learning and AI technologies, alongside accelerated synthesis methods, to swiftly design, engineer, and manufacture innovative peptide conjugate drug candidates.
Share Price
$3.58
Last synced: 2026-08-14
Market Cap
$1.90M
Change (1 day)
1.42%
Change (1 year)
-95.70%
Country
US
Trade Decoy Therapeutics Inc. (DCOY)

Category

Healthcare
Revenue for Decoy Therapeutics Inc. (DCOY)
Revenue in Aug 2026 TTM: 0
According to Decoy Therapeutics Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Decoy Therapeutics Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE